ACB
$1.430 (1.42%)
ACNNF
$0.030 (0%)
AERO
$3.210 (0%)
ALEAF
$0.050 (-14.97%)
AMMJ
$0.048 (12.81%)
APHA
$15.380 (0%)
ARNA
$99.990 (0%)
ATT:CNX
$0.080 (0%)
AUSA:CNX
$0.065 (0%)
AUSAF
$0.050 (0%)
AVXL
$11.060 (-0.98%)
BAMM:CNX
$0.130 (0%)
BBM:CNX
$0.030 (-14.29%)
BBRRF
$0.027 (-3.27%)
BE:CNX
$0.005 (0%)
BIO:CNX
$0.013 (0%)
BLIS:CNX
$0.315 (0%)
BLO:CNX
$0.395 (2.6%)
BLOZF
$0.308 (2.5%)
BUDZ
$0.100 (-9.09%)
CADMF
$0.052 (0%)
CALI:CNX
$0.085 (13.33%)
CANN
$0.230 (-2.13%)
CARA
$9.060 (-6.69%)
CBWTF
$0.062 (0.16%)
CGC
$2.540 (-0.97%)
CGRW
$0.016 (-22%)
CHOO:CNX
$0.005 (0%)
CHOOF
$0.003 (-16%)
CNBX
$3.990 (0%)
CNGGF
$0.203 (0%)
CODI
$22.680 (0.22%)
CPMD
$0.020 (-4.81%)
CRBP
$0.281 (0.07%)
CRON
$3.050 (0.33%)
CROP:CNX
$0.015 (0%)
CSI:CNX
$0.070 (-12.5%)
CURR
$0.349 (2.65%)
CVSI
$0.033 (7.49%)
DIGP
$0.014 (0%)
EEVVF
$0.078 (0%)
EMHTF
$0.039 (10.17%)
EPWCF
$0.059 (0%)
FFT:CNX
$0.040 (0%)
FNNZF
$0.075 (13.64%)
GNBT
$0.001 (0%)
GRIN:CNX
$0.075 (-16.67%)
GRWG
$4.840 (-1.83%)
GTBIF
$10.150 (-1.46%)
GTII:CNX
$13.090 (-1.65%)
GWPH
$218.960 (0%)
HEXO
$0.196 (-0.56%)
HHPHF
$0.079 (0%)
HLSPY
$0.363 (0%)
HMLSF
$2.800 (0%)
HMPPF
$0.498 (0%)
HRVOF
$0.023 (-11.07%)
HSTRF
$0.135 (0%)
HUGE:CNX
$1.180 (-1.67%)
IAN:CNX
$0.075 (0%)
IGC
$0.520 (-3.02%)
IGXT
$0.219 (13.76%)
IIPR
$92.910 (-2.5%)
INQD
$0.009 (-3.23%)
IONC:CNX
$0.005 (0%)
IONKF
$0.005 (-2.04%)
ISOL:CNX
$0.035 (0%)
ITHUF
$0.062 (5.65%)
KBEV:CNX
$0.045 (0%)
KHRNF
$0.091 (-2.15%)
KSHB
$0.695 (0%)
LHS:CNX
$1.470 (0%)
LHSIF
$1.145 (0%)
LXX:CNX
$8.400 (0%)
MCIG
$0.028 (0%)
MEDIF
$0.057 (1.15%)
MGWFF
$0.060 (9.57%)
MJ:CNX
$0.050 (0%)
MJNA
$0.015 (1.4%)
MNTR
$0.040 (0%)
MYM:CNX
$0.140 (0%)
MYMMF
$0.106 (0%)
NCNNF
$0.058 (0%)
NDVAF
$0.111 (-6.17%)
NGW:CNX
$0.410 (0%)
NRXCF
$0.035 (0%)
NSPDF
$0.010 (-23.53%)
NVTQF
$0.596 (0%)
NWKRF
$0.424 (0%)
NXGWF
$0.316 (0%)
NXTTF
$0.033 (6.61%)
OH:CNX
$5.330 (0%)
ORHOF
$4.050 (0%)
PHCG
$0.001 (0%)
PHVAF
$0.038 (0%)
PILL:CNX
$0.230 (-17.86%)
PKG:CNX
$0.020 (-20%)
PLPRF
$0.357 (0%)
PLUS:CNX
$0.440 (0%)
PMCB
$2.420 (0%)
PNPL
$0.012 (0%)
PTNYF
$0.018 (3.24%)
QCA:CNX
$0.095 (-5%)
RDDTF
$0.020 (1.53%)
RLLVF
$0.001 (0%)
RMHB
$0.028 (2.8%)
RQB:CNX
$0.005 (0%)
RQHTF
$0.448 (2.99%)
SLNG:CNX
$0.095 (-9.52%)
SMG
$83.180 (-1.21%)
SNN:CNX
$0.155 (0%)
SOL:CNX
$0.320 (0%)
SOLCF
$0.250 (0%)
SPLIF
$0.016 (-15.79%)
SPRWF
$0.268 (0%)
STEM:CNX
$0.035 (0%)
STMH
$0.028 (1.45%)
SUN:CNX
$0.150 (0%)
TBPMF
$0.052 (3.82%)
TCAN:CNX
$0.135 (0%)
TCNAF
$0.080 (0%)
TER:CNX
$3.480 (-0.57%)
TGEN
$1.200 (0%)
TGIF:CNX
$0.025 (-16.67%)
TGIFF
$0.020 (-12.28%)
THC:CNX
$0.048 (0%)
THCBF
$0.044 (12.85%)
TLRY
$3.540 (1.14%)
TRLFF
$0.035 (0%)
TRSSF
$2.710 (0.37%)
TURV
$0.001 (0%)
VIDA:CNX
$0.055 (0%)
VIN:CNX
$0.015 (0%)
VPRB
$0.047 (-6%)
VRTHF
$0.026 (0%)
VVCIF
$0.035 (-8.14%)
WAYL:CNX
$0.740 (0%)
XXII
$1.740 (-12.12%)
ZDPY
$0.740 (-2.63%)
ZYNE
$1.190 (-0.83%)
So far, 2021 is proving to be a banner year for the Latin American cannabis market and this is a trend that we are closely following. The industry has benefited from being able to export cannabis and hemp products to the European Union (EU), in addition to Colombia offering insurance…
Khiron Life Sciences Inc. (TSX Venture: KHRN) (OTC: KHRN) is a cannabis company that is flying under the radar and is one that we are closely following. The Latin American cannabis company is focused on improving people’s quality of life and we are favorable on how the management team has…
Khiron Life Sciences Corp. (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today announces its support for amendments to Colombia's medical cannabis decree, signed July 23, 2021 . With the enhanced regulations, Colombia continues to be a…
2021 is proving to be a banner year for Khiron Life Sciences Corp. (TSXV: KHRN) (OTCMKTS: KHRNF) and this is a story that we are closely following. Specifically, we are impressed with how Khiron is capitalizing on emerging international markets in the European Union (EU) as well as in Latin…
Last week, Khiron announced a major milestone and reported to have successfully completed its first sale of medical cannabis product in Brazil. By leveraging production, distribution, marketing agreements with leading pharmaceutical distributors, and clinical assets in Latin America, Khiron plans to expand its presence in Brazil. One of the reasons…
One of the most important trends in the cannabis sector is related to environmental, social, and governance (ESG) concerns. During the last month, we have seen a significant increase in the number of companies that are focused on addressing these concerns. Going forward, we expect the ESG trend to become…
So far this year, the North American cannabis industry has recorded impressive advancements, and this is a trend that we are closely following. From a conservative US Supreme Court Justice calling cannabis regulation outdated to Mexico's Supreme Court decriminalizing recreational cannabis, we are favorable on the legalization trend and believe…
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today reiterates its plans to enter the Mexican medical cannabis market in 2021, following a landmark vote by the Mexican…
2021 is proving to be a banner year for Khiron Life Sciences Corp. (TSXV: KHRN) (OTCMKTS: KHRNF) and this is a story that we are closely following. Specifically, we are impressed with how Khiron is capitalizing on emerging international markets in the European Union (EU) as well as in Latin…
Khiron Life Sciences Corp. (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today announces regulatory and supply chain advances that accelerate Khiron's entry into the Mexican market by several months. Leveraging the Company's designation in Colombia as…